- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| FILAMENT HEALTH Aktie jetzt für 0€ handeln | |||||
| Fr | Filament Health reports Q3 results | 3 | Seeking Alpha | ||
| Fr | Filament Health Announces Third Quarter 2024 Financial Results And Operational Highlights | 2 | CNW | ||
| 10.10. | Jaguar Health, Inc.: Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, to Present October 16 at BIO Investor Forum | 351 | ACCESSWIRE | Magdalena aiming to submit Investigational New Drug (IND) application in early 2025 to the FDA for a next-generation psychoactive prescription drug candidate for potential mental health indications... ► Artikel lesen | |
| 04.10. | Filament Health Corp: Filament issues 5.6 million shares under advisory deal | 1 | Stockwatch | ||
| 04.10. | Filament Health Announces Issuance Of Common Shares To Negev Capital Investments Limited Pursuant To Advisory Agreement | 1 | CNW | ||
| 14.08. | Filament Health Announces Second Quarter 2024 Financial Results And Operational Highlights | 1 | CNW | ||
| 13.08. | Filament Health Corp: Filament has 12 patents accepted by IP Australia | 1 | Stockwatch | ||
| 13.08. | Filament Health Announces Major Intellectual Property Expansion | 1 | CNW | ||
| 15.06. | Negev Capital Fund One, L.P. Reports Updated Holdings in Filament Health Corp. | 470 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - June 14, 2024) - Negev Capital Fund One, L.P. (the "Acquiror"), a shareholder of Filament Health Corp. ("Filament"), announces that on June 12, 2024,... ► Artikel lesen | |
| 13.06. | Filament Health Corp: Filament Health completes $1-million bridge financing | 1 | Stockwatch | ||
| 12.06. | Filament Health Announces Closing Of Warrant Exercise, Note Conversion And Concurrent Private Placement Of Common Shares | 2 | CNW | ||
| 03.06. | Filament Health Corp: Filament, Negev arrange note, warrant exercise | 1 | Stockwatch | ||
| 03.06. | Filament Health Corp: Filament cleared for phase 2 PEX010 clinical trial | 1 | Stockwatch | ||
| 03.06. | Filament Health Announces Warrant Exercise And Note Conversion By Negev Capital And Concurrent Private Placement Of Common Shares To Benjamin Lightburn, Chief Executive Officer | 1 | CNW | ||
| 03.06. | Filament Health Announces Authorization Of Phase 2 Clinical Trial For Pex010 In The Treatment Of Methamphetamine Use Disorder | 1 | CNW | ||
| 30.01. | Jaguar Health, Inc.: Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, Study Indicates Psychoactive Activity of Medicinal Plant Utilized for Centuries by Indigenous Peoples in Tropical Regions | 728 | ACCESSWIRE | Magdalena aiming to submit Investigational New Drug application in 2024 to the FDA for this next-generation psychoactive prescription drug candidate for potential mental health indications such as ADHD... ► Artikel lesen | |
| 20.12.23 | Jupiter Acquisition Corporation Announces Mutually Agreed Termination of Business Combination Agreement With Filament Health Corp., Cancellation of Special Meeting of Stockholders and Redemption of Public Shares | 221 | GlobeNewswire (Europe) | Hobe Sound, FL, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Jupiter Acquisition Corporation (NASDAQ:JAQC) ("Jupiter") today announced the mutually agreed termination of the previously announced business combination... ► Artikel lesen | |
| 07.12.23 | XFRA 7QS: WIEDERAUFNAHME/RESUMPTION | 217 | Xetra Newsboard | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| 06.12.23 | XFRA 7QS: AUSSETZUNG/SUSPENSION | 314 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILFILAMENT HEALTH... ► Artikel lesen |
19 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BAYER | 19,556 | +0,06 % | Aurubis, Bayer, Evonik, Rheinmetall, ThyssenKrupp, Verbio u.a. - Aktien-Positionen der Shortseller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| AURORA CANNABIS | 4,202 | +4,32 % | Aurora Cannabis Inc (3): Aurora Cannabis releases new recreational products | ||
| CANOPY GROWTH | 3,785 | +6,17 % | Jetzt wird es brenzlig: Kurse von Tilray, Canopy & Co. brechen massiv ein. So heftig könnte es werden | © Foto: Piyapong Thongdumhyu - 123rf StockfotoRund um die US-Wahl fielen weitere Entscheidungen. Während der Cannabis-Sektor die Wahl Trumps zum nächsten US-Präsidenten noch nicht so ganz einordnen... ► Artikel lesen | |
| TILRAY BRANDS | 1,280 | +4,11 % | Tilray Brands, Inc.: Redhook Brewery and Montlake Futures Team Up to Launch Montlake Gameday Gold Lager, a New Craft Beer in Support of University of Washington Athletes | ||
| INNOCAN PHARMA | 0,158 | +13,67 % | Breaking News: InnoCan Pharma erzielt 24 Mio. USD Umsatz… | ||
| CRONOS GROUP | 1,937 | +1,79 % | Cronos Group Inc. (CRON): A Bull Case Theory | ||
| SYNBIOTIC | 5,500 | -2,83 % | EQS-News: SYNBIOTIC SE: In voller Blüte: WEECO Pharma stärkt Umsatz von SYNBIOTIC | EQS-News: SYNBIOTIC SE
/ Schlagwort(e): Sonstiges
In voller Blüte: WEECO Pharma stärkt Umsatz von SYNBIOTIC
14.11.2024 / 13:30 CET/CEST
Für den Inhalt der Mitteilung... ► Artikel lesen | |
| GREEN THUMB INDUSTRIES | 9,045 | -0,82 % | Grünes Gold!: Gesundheit so wichtig wie nie! Medizinische Revolution durch diese Aktie! | ||
| CHRISTINA LAKE CANNABIS | 0,018 | 0,00 % | Christina Lake Cannabis Corp: Christina Lake to complete $3.6M private placement | ||
| AXSOME THERAPEUTICS | 90,56 | +0,94 % | Axsome Therapeutics Aktie: Erfolgsquote steigt rasant! | Die Axsome Therapeutics Aktie verzeichnete am 9. November 2024 einen marginalen Rückgang von 0,69% auf 90,07 USD. Trotz dieses leichten Kursverlusts bleibt das Unternehmen auf Wachstumskurs. Mit einer... ► Artikel lesen | |
| JAGUAR HEALTH | 0,965 | 0,00 % | Jaguar Health, Inc.: Jaguar Health Family Company Napo Therapeutics Named "Best Pharmaceuticals Innovator of the Year - Europe" | Established in Milan, Italy in 2021, Napo Therapeutics is focused on expanding access to crofelemer, Jaguar's novel oral plant-based prescription drug, in Europe for orphan and/or rare diseases SAN... ► Artikel lesen | |
| JAZZ PHARMACEUTICALS | 114,45 | +1,10 % | Jazz Pharmaceuticals plc: Jazz Pharmaceuticals Announces U.S. FDA Approval of Ziihera (zanidatamab-hrii) for the Treatment of Adults with Previously Treated, Unresectable or Metastatic HER2-positive (IHC 3+) Biliary Tract ... | Ziihera is the first and only dual HER2-targeted bispecific antibody approved for HER2+ BTC in the U.S.Ziihera received accelerated approval based on results including a 52% objective response... ► Artikel lesen | |
| TRULIEVE CANNABIS | 6,000 | +0,08 % | Trulieve Cannabis Corp: Trulieve opens two new dispensaries in Florida | ||
| JUVA LIFE | 0,023 | -100,00 % | Juva Life Inc. Updates Shareholders on Financial Status and Upcoming Receivership Hearing | REDWOOD CITY, CA / ACCESSWIRE / November 5, 2024 / Juva Life Inc. (CSE:JUVA)(OTC EXPERT MARKET:JUVAF)(FRANKFURT:4VV) ("Juva" or the "Company"), a life science company with both pharmaceutical research... ► Artikel lesen | |
| CORBUS PHARMACEUTICALS | 15,100 | -1,31 % | Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Short Interest Down 13.5% in October |
FILAMENT HEALTH CORP gehört der Branche Pharma an. Die relative Kursveränderung beträgt aktuell +4,88 % bei einem Aktienkurs von 0,022 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu FILAMENT HEALTH CORP finden Sie auf Wallstreet Online.
